BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2501 related articles for article (PubMed ID: 19238148)

  • 1. Cell cycle, CDKs and cancer: a changing paradigm.
    Malumbres M; Barbacid M
    Nat Rev Cancer; 2009 Mar; 9(3):153-66. PubMed ID: 19238148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the "Cdk-centric" view of the mammalian cell cycle.
    Malumbres M
    Cell Cycle; 2005 Feb; 4(2):206-10. PubMed ID: 15655365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs.
    Risal S; Adhikari D; Liu K
    Methods Mol Biol; 2016; 1336():155-66. PubMed ID: 26231715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
    Klein MA
    Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclins and related kinases in cancer cells.
    Malumbres M
    J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell cycle and parathyroid tumor].
    Matsushime H
    Nihon Rinsho; 1995 Apr; 53(4):844-9. PubMed ID: 7752470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of the G1/S transition.
    Reed SI
    Cancer Surv; 1997; 29():7-23. PubMed ID: 9338094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
    Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
    J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts in neuro-oncology: the cell cycle--a review.
    Dirks PB; Rutka JT
    Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer.
    Ding L; Cao J; Lin W; Chen H; Xiong X; Ao H; Yu M; Lin J; Cui Q
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.
    Bendris N; Lemmers B; Blanchard JM
    Cell Cycle; 2015; 14(12):1786-98. PubMed ID: 25789852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
    Ravitz MJ; Wenner CE
    Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G1 control in mammalian cells.
    Reed SI; Bailly E; Dulic V; Hengst L; Resnitzky D; Slingerland J
    J Cell Sci Suppl; 1994; 18():69-73. PubMed ID: 7883795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers.
    Chohan TA; Qayyum A; Rehman K; Tariq M; Akash MSH
    Biomed Pharmacother; 2018 Nov; 107():1326-1341. PubMed ID: 30257348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
    Santo L; Siu KT; Raje N
    Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 126.